References
 
  1. Ross DS. Subclinical hypothyroidism. In Werner and Ingbar’s The Thyroid, a Fundamental and Clinical Text, eds Braverman LE and Utiger RD, Seventh Edition, JP Lippincott-Raven Publishers, Philadelphia-New York, 1996, p. 1010-1015.


  2. Fenzi G, Salvatore D, de Riu S, Marrano L, Vitale M. Subclinical hypothyroidism. In The Thyroid and Age, eds Pinchera A, Mann K, and Hostalek U, Merck European Thyroid Symposium 1998, April 30–May 2, Schattauer, Stuttgart-New York, 1998, p. 305-314.


  3. Tunbridge WMG, Evered DC, Hall R, Appleton D, Prenis M, Clark F, Grimley Evans J, Young E, Bird T, Smith PA. The spectrum of thyroid disease in a community: The Whickham survey. Clin Endocrinol 1997; 7: 481-493.


  4. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid: thyroid deficiency in the Framingham Study. Arch Inter Med 1985; 145: 1386-1388.


  5. Wang C, Crapo LM. The epidemiology of thyroid disease and implication for screening. Endocrinol Metab Clin N Amer 1997; 26: 189-218.


  6. Gray RS, Barsey DQ, Seth J, Herd R, Brown NS, Clarke BF. Prevalence of subclinical thyroid failure in insulin-dependent diabetes. J Clin Endocrinol Metab 1980; 50: 1034-1037.


  7. Klein RZ, Haddow JE, Faix JD, Brown RS, Hermos RJ, Pulkkinen A, Mitchell ML. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol 1991; 35: 41-46.


  8. Surks MI, Ocampo E. Subclinical thyroid disease. Amer J Med 1996; 100: 217-223.


  9. Delange F, Hershman JM, Ermans AM. Relationship between the serum thyrotropin level, the prevalence of goiter and the pattern of iodine metabolism in Idjwi island. J Clin Endocrinol Metab 1971; 33: 261-268.


  10. Patel YC, Pharoah POD, Hornabrook RW, Hetzel BS. Serum triiodothyronine, thyroxine and thyroid-stimulating hormone in endemic goiter: a comparison of goitrous and nongoitrous subjects in New Guinea. J Clin Endocrinol Metab 1973; 37: 783-789.


  11. Chopra IJ, Hershman JM, Hornabrook RW. Serum thyroid hormone and thyrotropin levels in subjects from endemic goiter regions of New Guinea. J Clin Endocrinol Metab 1975; 40: 326-333.


  12. Weetman AP. Hypothyroidism: screening and subclinical disease. Brit Med J 1997; 314: 1175-1178.


  13. Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA 1996; 276: 285-292.


  14. Buchanan WW, Harden RMcG, Koutras DA, Gray KG. Abnormalities of iodine metabolism in patients with complement-fixing antimicrosomal thyroid autoantibodies, but not clinical evidence of thyroid disease: a sub-clinical form of Hashimoto’s thyroiditis. J Clin Endocrinol Metab 1965; 25: 301-306.


  15. Bastenie PA, Vanhaelst BL, Neve P. Coronary heart disease in hypothyroidism. Observations in preclinical myxoedema. Lancet 1967; 2: 1221-1222.


  16. Kung AWC, Pang RWC, Janus ED. Elevated serum lipoprotein (a) in subclinical hypothyroidism. Clin Endocrinol 1995; 43: 445-449.


  17. Caron P, Calazel C, Parra HJ, Hoff M, Louvet JP. Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-T4 therapy. Clin Endocrinol (Oxf) 1990; 33: 519-523.


  18. Pallas D, Koutras DA, Adamopoulos P, Marafelia P, Souvatzoglou A, Piperingos G, Moulopoulos SD. Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients: does it mean occult hypothyroidism? J Endocrinol Invest 1991; 14: 743-746.


  19. Althaus BU, Staub JJ, Ryff AS, Léche A, Oberhansli A, Stahelin HB. LDL-HDL-changes in subclinical hypothyroidism: A possible risk factor for coronary artery disease. Clin Endocrinol 1988; 28: 157-163.


  20. Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, Burcckhardt D, Girard J, Weintraub BD. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992; 92: 631-642.


  21. Tanis BC, Westerdorp BGI, Smelt AHM. Effect of thyroid substitution on hypercholesterolemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin Endocrinol 1996; 44: 643-649.


  22. Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P, Mantzos J, Stamatelopoulos S, Koutras DA. Flow-mediated, endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 1997; 7: 411-414.


  23. Ladenson PW. Recognition and management of cardiovascular disease related to thyroid dysfunction. Am J Med 1990; 88: 638-642.


  24. Duntas LH, Papanastasiou L, Mantzou E, Koutras DA. Incidence of sideropenia and effects of iron repletion treatment in women with subclinical hypothyroidism. Exp Clin Endocrinol Diabetes 1999; in press.


  25. Monzani F, Caraccio N, Siciliano G, Manca L, Murri L, Ferrannini E. Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J Clin Endocrinol Metab 1997; 82: 3315-3318.


  26. Goulis DG, Tsimpiris N, Delaroudis S, Maltas B, Tzoiti M, Dagilas A, Avramides A. Stapedial reflex: a biologic index found to be abnormal in clinical and subclinical hypothyroidism. Thyroid 1998; 8: 583-587.


  27. Joffe RT, Levitt AJ. Major depression and subclinical (grade 2) hypothyroidism. Psychoneuroendocrinology 1992; 17: 215-221.


  28. Haggerty JJJr, Stern RA, Mason GA. Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry 1993; 150: 508-510.


  29. Monzani F, Del Guerra P, Caraccio N, Prunetti CA, Puzzi E, Luisi M. Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Invest 1993; 71: 367-371.


  30. Pop VJ, Maartens LH, Leusink G, van Son MJ, Knottnerus AA, Ward AM, Metcalfe R, Weetman AP. Are autoimmune thyroid dysfunction and depression related? J Clin Endocrinol Metab 1998; 83: 3194-3197.


  31. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-thyroxine therapy in subclinical hypothyroidism. Ann Intern Med 1984; 101: 18-24.


  32. Nystrom E, Caidahl K, Fager G, Wikkelsö C, Lundberg PA, Lindstedt G. A Double-blind cross-over 12 month study of L-thyroxine treatment of women with ‘subclinical’ hypothyroidism. Clin Endocrinol (Oxf) 1988; 29: 63-76.


  33. Diekman T, Lansberg PJ, Kastelein JJP, Wiersinga WM. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med 1995; 155: 1490-1495.


  34. Samuels MH. Subclinical thyroid disease in the elderly. Thyroid, 1998; 9: 803-813.


  35. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Evans JG, Hasan DM, Rogders H, Tunbridge F, Young ET. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55-68.


  36. Michalopoulou G, Alevizaki M, Piperingos G, Mitsibounas D, Mantzos J, Adamopoulos P, Koutras DA. High serum cholesterol levels in persons with "high-normal" TSH levels: should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol 1998; 138: 141-145.